Am. J. Respir. Crit. Care Med., Vol 152, No. 1, Jul 1995, 377-380.
5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways
T Takahashi, JK Ward, S Tadjkarimi, MH Yacoub, PJ Barnes and MG Belvisi
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.
5-hydroxytryptamine (5-HT) may not play a major role in controlling human
airway smooth muscle tone, as it has little direct effect on airway
caliber. However, its role as a neuromodulator has not been determined. We
have identified a facilitatory effect of 5-HT on cholinergic
neurotransmission and characterized the 5-HT receptors involved in human
and guinea pig trachea. In guinea pig trachea, 5-HT facilitated electric
field stimulation-induced cholinergic bronchoconstriction in a
concentration-dependent manner (EC50 = 2.6 microM). The 5-HT3/4 and 5-HT3
antagonists, ICS 205-930 and ondansetron, inhibited the effect of 5-HT
competitively (pA2 values of 7.3 and 7.1, respectively); methiothepin
(5-HT1/2C antagonist), ketanserin (5-HT2A antagonist), and GR 113808A
(5-HT4 antagonist) had no effect. The rank order of potency of 5-HT
agonists was 5-HT > 2- methyl-5-HT (5-HT3 selective) >
5-methoxytryptamine (5-HT4 selective) > alpha-methyl-5-HT (5-HT2
selective). 5-carboxamidotryptamine (5- HT1A/B/D) and sumatriptan (5-HT1D
selective) were essentially inactive. 5-Hydroxytryptamine had no effect on
contractile responses to exogenous acetylcholine, suggesting that 5-HT
facilitates cholinergic bronchoconstriction via prejunctional receptors. In
human bronchi, 5-HT also facilitated cholinergic bronchoconstriction, which
was inhibited by ICS 205-930. The effects of the 5-HT3 antagonists and
selective agonists in human and guinea pig airways suggests that these
facilitatory effects are mediated by 5-HT3 receptors.